Ketamine vs. Spravato: What’s the Difference?

02/23/2026

9 minute read

Key Takeaways:

Spravato vs. Ketamine: Spravato is an FDA-approved esketamine nasal spray with strict monitoring requirements, while ketamine therapy often involves off-label IV infusions or other forms with varying clinic protocols.
Safety and Supervision: Spravato requires in-clinic administration and observation under a REMS program, whereas ketamine therapy’s safety standards differ by provider, making clinic evaluation crucial.
Cost and Insurance: Spravato is more likely to be covered by insurance, while ketamine therapy is typically self-pay, with costs varying widely.
Effectiveness and Risks: Both treatments can provide rapid relief for treatment-resistant depression, but they are not cures. Ketamine carries a risk of misuse and addiction, requiring careful consideration and medical guidance.

Question:

Ketamine vs. Spravato: What’s the difference?

Answer:

Ketamine and Spravato offer hope for those with treatment-resistant depression, but they differ significantly. Spravato, an FDA-approved esketamine nasal spray, is administered under strict supervision, making it a structured and insurance-friendly option. Ketamine therapy, often off-label, includes IV infusions or other forms with varying clinic protocols and costs, typically paid out-of-pocket. Both treatments can provide rapid symptom relief, but they are not cures and should be part of a broader mental health plan. Safety is paramount, as ketamine carries a risk of misuse and addiction. Choosing the right option requires understanding these differences, evaluating clinic standards, and consulting a qualified provider.

When traditional antidepressants haven’t provided relief, the promise of a fast-acting solution can offer a powerful sense of hope. You may have heard about ketamine therapy and a related medication called Spravato as options for treatment-resistant depression. The names are often used together, leading to a common question: “Isn’t Spravato just another form of ketamine?”

While they are related, they are not the same. Understanding the differences is crucial for making an informed and safe decision about your mental health care. This article will help you compare ketamine and Spravato by exploring the medication type, FDA approval status, how each is administered, safety monitoring, costs, and who might be a candidate for each.

Not sure what’s right for you? The team at Footprints to Recovery can help you understand your options for mental health and substance use concerns. Call us today.

At a Glance: The Biggest Differences

For those looking for a quick comparison, here are the main distinctions:

Spravato® is the brand name for esketamine, a prescription nasal spray. It is a specific component of the ketamine molecule. It’s FDA-approved and used under a strict, supervised program with required safety monitoring.
Ketamine therapy usually refers to the off-label use of ketamine, often administered through IV infusions. It can also be given as an injection (IM), oral lozenge, or compounded nasal spray. The protocols for this type of therapy can vary widely from one clinic to another.
Insurance coverage is more common for Spravato treatment due to its FDA approval. Ketamine infusions, being off-label, are often paid for out-of-pocket by the patient.

Feature	Spravato (esketamine)	Ketamine Therapy (e.g., IV Infusion)
FDA Approval	Approved for treatment-resistant depression (TRD) and major depressive disorder (MDD) with acute suicidal ideation or behavior.	Not FDA-approved for depression (off-label use). Approved as an anesthetic.
Dosing Location	Must be administered in a certified healthcare setting.	Typically administered in a private clinic.
Monitoring	Mandatory post-dose observation for at least two hours by a healthcare provider.	Monitoring protocols vary significantly between clinics.
Typical Frequency	Starts with twice-weekly sessions, then reduces over time based on response.	Varies by clinic; often a series of initial infusions followed by boosters.
Insurance	More likely to be covered by insurance, though plans vary.	Typically self-pay.

What Is Ketamine?

Ketamine first gained prominence as a powerful anesthetic used in medical settings for surgery. It is also known as a recreational drug that is misused for its dissociative effects. In recent years, its potential to rapidly alleviate symptoms of depression has led to its use in mental health treatment.

When you hear about ketamine for depression, it can refer to several forms:

IV (intravenous) infusion: Administered directly into the bloodstream.
IM (intramuscular) injection: Injected into a muscle.
Oral/sublingual: A lozenge or tablet that dissolves in the mouth.
Compounded nasal sprays: Specially mixed by a pharmacy.

It is vital to recognize that ketamine carries a risk of addiction and can be harmful when misused. Understanding the signs of problematic use is essential for anyone considering this treatment.

What Is Spravato (esketamine)?

Spravato is the brand name for a prescription nasal spray containing esketamine. Esketamine is one of the two molecules that make up the ketamine compound. It is specifically formulated and FDA-approved for adults with treatment-resistant depression and for those with major depressive disorder who are experiencing suicidal thoughts or behaviors.

What makes Spravato distinct is its standardized approach. The dosage, administration, and safety protocols are all part of a structured clinical program, ensuring a consistent standard of care.

FDA Approval and Regulation: “Approved” vs. “Off-Label”

The regulatory status of these two treatments is a major point of difference and directly impacts how they are provided.

Spravato’s REMS Program

Because of its potential side effects and risk of misuse, Spravato is only available through a restricted program called a Risk Evaluation and Mitigation Strategy (REMS). This FDA-mandated program requires that:

Patients self-administer the nasal spray under the direct supervision of a healthcare provider in a certified clinic.
Patients are monitored by a professional for at least two hours after the dose due to risks like sedation, dissociation, and blood pressure changes.

Ketamine Therapy’s Status

Ketamine is not FDA-approved for treating depression. Its use for this purpose is considered “off-label,” meaning a doctor prescribes it for a condition other than what it was officially approved for. While off-label prescribing is a common and legal practice, it also means there are no federally enforced standards for how ketamine therapy for depression should be administered.

This lack of standardization leads to significant variability between clinics in terms of patient screening, dosing, safety monitoring, and follow-up care. If you are comparing providers, it’s crucial to ask about their safety protocols.

How Each Is Administered: What a Session Looks Like

The experience of receiving Spravato versus ketamine is quite different.

A Spravato Session

A Spravato treatment session always takes place at a certified clinic. You will self-administer the prescribed dose under supervision. Afterward, you’ll relax in a comfortable, monitored environment for at least two hours. During this time, a healthcare provider will check your blood pressure and watch for side effects. Because of the potential for sedation, you cannot drive, operate machinery, or make important decisions for the rest of the day and must arrange for transportation home.

A Ketamine Therapy Session

A typical ketamine therapy session involves receiving an IV infusion in a private clinic setting. The duration of the infusion can vary. While some clinics provide comprehensive monitoring similar to the Spravato REMS program, others may not. The quality and safety standards can differ greatly, so it is important to evaluate a clinic’s procedures carefully.

What to Ask a Ketamine Clinic
Who administers the treatment and what are their qualifications?
What medical monitoring is provided during and after the session?
What emergency equipment and protocols are in place?
Do you screen for conditions that may make ketamine unsafe?
Is psychotherapy or integration therapy offered as part of the treatment plan?

Effectiveness and What “Rapid Relief” Really Means

Many people report a significant improvement in their depression symptoms within hours or days of treatment with either ketamine or Spravato. However, “rapid relief” does not mean it’s a permanent cure.

These treatments are most effective as part of a comprehensive mental health plan that may include ongoing therapy, other medications, and lifestyle changes. The durability of the effects varies from person to person, and maintenance sessions are often required. The decision to pursue either option should always be made in close consultation with a qualified medical provider who understands your individual health history.

Side Effects and Safety Considerations

Supervision is critical because both treatments can cause powerful short-term side effects.

Common Short-Term Effects

Dissociation (feeling disconnected from your thoughts, body, or environment)
Dizziness and nausea
Sedation or drowsiness
Temporary increase in blood pressure

Misuse Risk and Addiction Concerns

Because ketamine is a drug of misuse, there is a legitimate concern about the potential for addiction. Long-term, non-medical use can lead to serious health consequences, including cognitive problems, mental health decline, and severe bladder and kidney damage. It’s important to be honest about any personal or family history of substance use disorder with your doctor. Recognizing patterns of problematic use, such as craving the drug or seeking it outside of a medical setting, is the first step toward seeking help.

If you are worried about your or a loved one’s ketamine use, understanding the signs and symptoms is crucial. Our admissions team can provide a confidential assessment.

Cost and Insurance: What to Expect

Financial considerations are a practical part of the decision-making process. Verifying your insurance can answer any questions you may have about coverage.

Spravato

Because Spravato is an FDA-approved medication with a specific indication for treatment-resistant depression, it is more likely to be covered by commercial insurance plans and Medicare. However, patients may still be responsible for co-pays, deductibles, or costs associated with the monitoring visits.

Ketamine Infusions

Ketamine infusions for depression are considered off-label, so they are rarely covered by insurance. Patients typically pay for these treatments out-of-pocket. Costs can vary dramatically based on the clinic, its location, and the specific treatment protocol, often ranging from several hundred to over a thousand dollars per session.

Want help understanding your options and potential pathways to care? Call Footprints to Recovery for a confidential assessment.

Who Might Consider Which Option?

This is not medical advice, but a guide to help you have a more informed conversation with your healthcare provider.

Spravato may be a better fit if…

You prefer an FDA-approved treatment with a standardized, structured safety program.
You need to use insurance to help cover the cost of treatment.

Ketamine therapy may be considered if…

A trusted clinician has determined that off-label ketamine is a suitable option for your specific case.
You have thoroughly vetted and selected a reputable clinic with high safety and monitoring standards.

Consider extra caution if…

You have a personal or family history of substance use disorder. A provider specializing in dual diagnosis—treating both mental health and substance use—is essential for ensuring safety and providing integrated support.

How Footprints to Recovery Can Help

Navigating treatment options for depression can feel overwhelming, especially when substance use is also a concern. At Footprints to Recovery, we provide a path forward through our depression disorder treatment in Elgin, IL.

If you are seeking help for depression, our team can conduct a comprehensive evaluation to recommend evidence-based mental health care, which may include our Spravato treatment program.

If you are worried about ketamine misuse or addiction, we offer a full continuum of care, from detox and residential treatment to outpatient programs. Our expertise in dual diagnosis ensures that we treat co-occurring mental health conditions and substance use disorders simultaneously for the best possible outcomes.

You don’t have to figure this out alone. Contact our admissions team today to learn more.

Frequently Asked Questions

Is Spravato the same thing as ketamine?
No. Spravato contains esketamine, which is one part of the ketamine molecule. While related, they are chemically distinct. Spravato is a regulated, FDA-approved nasal spray, whereas ketamine therapy often uses the full ketamine molecule in an off-label IV infusion.

Why do I have to stay at the clinic after Spravato?
The required two-hour observation period is a crucial safety measure. It allows your healthcare provider to monitor you for potential side effects like sedation, dissociation, and changes in blood pressure until they have subsided.

Can ketamine be addictive?
Yes. Ketamine has a known potential for misuse and addiction. It’s important to use it only under strict medical supervision and to be aware of the signs of problematic use.

Will insurance cover ketamine or Spravato?
It depends. Spravato is more likely to be covered by insurance since it is FDA-approved for depression. Ketamine infusions are generally not covered and are paid out-of-pocket. Always check with your insurance provider.

What should I ask a ketamine clinic before starting?
Ask about their screening process, medical monitoring during and after treatment, emergency protocols, and whether they offer integrated therapy to support your long-term mental health.